BidaskClub lowered shares of MiMedx Group (NASDAQ:MDXG) from a sell rating to a strong sell rating in a research note issued to investors on Saturday.
MDXG has been the subject of several other research reports. Needham & Company LLC reaffirmed a hold rating on shares of MiMedx Group in a research note on Thursday, March 15th. Craig Hallum reissued a buy rating on shares of MiMedx Group in a research note on Tuesday, February 27th. ValuEngine lowered MiMedx Group from a hold rating to a sell rating in a research note on Thursday, March 1st. Finally, Lake Street Capital set a $12.00 price objective on MiMedx Group and gave the company a buy rating in a research note on Wednesday, February 21st. Three research analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company’s stock. The stock has a consensus rating of Hold and a consensus price target of $16.00.
Get MiMedx Group alerts:
Shares of MDXG opened at $5.48 on Friday. The company has a market capitalization of $626.24 million, a price-to-earnings ratio of 26.86, a PEG ratio of 0.73 and a beta of 1.53. MiMedx Group has a 1 year low of $4.95 and a 1 year high of $18.25.
Several large investors have recently added to or reduced their stakes in the company. BlackRock Inc. boosted its stake in shares of MiMedx Group by 1.1% during the fourth quarter. BlackRock Inc. now owns 13,607,325 shares of the medical equipment provider’s stock valued at $171,588,000 after purchasing an additional 147,214 shares during the period. Consonance Capital Management LP purchased a new stake in shares of MiMedx Group during the fourth quarter valued at approximately $75,543,000. Millennium Management LLC boosted its stake in shares of MiMedx Group by 11.5% during the fourth quarter. Millennium Management LLC now owns 2,193,907 shares of the medical equipment provider’s stock valued at $27,665,000 after purchasing an additional 226,663 shares during the period. The Manufacturers Life Insurance Company boosted its stake in shares of MiMedx Group by 4.1% during the first quarter. The Manufacturers Life Insurance Company now owns 1,462,689 shares of the medical equipment provider’s stock valued at $10,195,000 after purchasing an additional 57,231 shares during the period. Finally, Senzar Asset Management LLC boosted its stake in shares of MiMedx Group by 24.2% during the first quarter. Senzar Asset Management LLC now owns 902,100 shares of the medical equipment provider’s stock valued at $6,288,000 after purchasing an additional 175,800 shares during the period. 75.30% of the stock is owned by hedge funds and other institutional investors.
MiMedx Group Company Profile
MiMedx Group, Inc, a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts.
